drugset / Trial / NCT05415475
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This trial is an open-label, single-arm clinical study. The main purpose is to verify the safety and efficacy of CAR-T cell preparations in the treatment of CEA-positive advanced malignant tumors, and to obtain the recommended dose and infusion scheme of CAR-T cell preparations for the treatment of patients with CEA-positive advanced malignant tumors.
Timeline
- Start
- 2021-09-10
- Primary completion
- 2025-06-15
- Completion
- 2025-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CEA CAR-T cells | Cell therapy | 1e+07 unknown | Intravenous |
| Subject | CEA CAR-T cells | Cell therapy | 1e+08 unknown | Intravenous |